Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zars amends IPO

Zars (Salt Lake City, Utah) amended its IPO and hopes to sell 5

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE